Now Streaming On-Demand
The webinar began with an introduction to abatacept, its mechanism of action, and its clinical indications. The speaker then discussed the challenges faced in the development of abatacept biosimilars, including analytical and clinical challenges.
The speaker also provided an overview of the regulatory landscape for abatacept biosimilars and discussed the key requirements for demonstrating bioequivalence.
He highlighted the importance of a comprehensive approach to bioanalysis, including preclinical studies, analytical method development, and clinical trial design.
The webinar also featured case studies illustrating the challenges and solutions encountered during the development and validation of abatacept biosimilar clinical assays.
The speaker shared his experiences in overcoming these challenges and offered insights into best practices for assay development and validation.
The webinar concluded with a question and answered session, providing attendees with the opportunity to ask the speakers for clarification on any of the topics discussed.
The session provided a valuable opportunity for attendees to learn about the latest approaches and solutions in the development of abatacept biosimilar clinical assays.